Newsroom
Careers
Contact Us
Home
About Us
Products
Manufacturing
R & D
Responsibility
Investors
Vision & Mission
Leadership Structure
Corporate Governance
Business Conduct & Ethics
Business Opportunities
Global Operations
History
Formulations
Active Pharamaceutical Ingredients
Goa
Baddi
Ghaziabad
Sikkim
Roha
Pithampur
Research Centre - Goa
Priority Areas
Biotechnology Capabilities
Research Alliances & Partnerships
Values & Commitments
Environment, Health & Safety
Quality & Reliability
CSR
Financial highlights
CEO & CFO Certifications
Shareholder Information
Contacts
Home
Investor Information
Financial highlights
Financial highlights
Annual Report
2010-11
Annual Report 2010-11
2009-10
Annual Report 2009-10
2008-09
Annual Report 2008-09
2007-08
Annual Report 2007-08
2006-07
Annual Report 2006-07
Quarterly report
December 31, 2011
Unaudited Financial Results for the quarter and half year ended December 31, 2011
Investor Update Q3 FY 2011-12
September 30, 2011
Unaudited Financial Results for the quarter and half year ended September 30, 2011
Investor Update Q2 FY 2011-12
June 30, 2011
Unaudited Financial Results for the quarter ended June 30, 2011
Investor Update Q1 FY 2011-12
March 31, 2011
Audited Financial Results for the year ended 31
st
March 2011
Investor Update FY 2010 -11
December 31, 2010
Unaudited Financial Results for the quarter and nine months ended 31
st
December 2010
Investor Update Q3 FY 2010-11
Investor Presentation
September 30, 2010
Unaudited Financial Results for the quarter and half year ended 30
th
September 2010
Investor Update Q2 FY 2010-11
June 30, 2010
Unaudited Financial Results for the quarter ended 30
th
June 2010
Investor Update Q1 FY 2010-11
March 31, 2010
Unaudited Financial Results for the quarter and year ended 31
st
March 2010
Investor Update Q4 FY 2009-10
December 31, 2009
Unaudited Financial Results For The Quarter Ended 31
st
December 2009
Investor Update Q3 FY 2009-10
September 30, 2009
Unaudited Financial Results For The Quarter & Half Year Ended 30
th
September 2009
Investor Update Q2 FY 2009-10
June 30, 2009
Unaudited Financial Results For The Quarter Ended 30
th
June 2009
Did you know?
Many of Unichem’s manufacturing facilities are FDA approved
Over 65% of depressed people don’t seek treatment
Our product, Losar is the #1 anti-hypertensive brand in India
More than 2% of pharmaceutical patenting in the US is by India-based inventors